Consistent with this mechanism, genetic and pharmacological inhibition of p53 can suppress neuroepithelial apoptosis in Tcof1+/- embryos and prevent the pathogenesis of craniofacial anomalies characteristic of TCS [37]. The gene discussed is TCOF1; the disease is Treacher-Collins syndrome.